Back to Search Start Over

Programmed Death-Ligand 2 Deficiency Exacerbates Experimental Autoimmune Myocarditis in Mice.

Authors :
Li, Siqi
Tajiri, Kazuko
Murakoshi, Nobuyuki
Xu, DongZhu
Yonebayashi, Saori
Okabe, Yuta
Yuan, Zixun
Feng, Duo
Inoue, Keiko
Aonuma, Kazuhiro
Shimoda, Yuzuno
Song, Zoughu
Mori, Haruka
Huang, Honglan
Aonuma, Kazutaka
Ieda, Masaki
Iaccarino, Guido
Source :
International Journal of Molecular Sciences; Feb2021, Vol. 22 Issue 3, p1426-1426, 1p
Publication Year :
2021

Abstract

Programmed death ligand 2 (PD-L2) is the second ligand of programmed death 1 (PD-1) protein. In autoimmune myocarditis, the protective roles of PD-1 and its first ligand programmed death ligand 1 (PD-L1) have been well documented; however, the role of PD-L2 remains unknown. In this study, we report that PD-L2 deficiency exacerbates myocardial inflammation in mice with experimental autoimmune myocarditis (EAM). EAM was established in wild-type (WT) and PD-L2-deficient mice by immunization with murine cardiac myosin peptide. We found that PD-L2-deficient mice had more serious inflammatory infiltration in the heart and a significantly higher myocarditis severity score than WT mice. PD-L2-deficient dendritic cells (DCs) enhanced CD4<superscript>+</superscript> T cell proliferation in the presence of T cell receptor and CD28 signaling. These data suggest that PD-L2 on DCs protects against autoreactive CD4<superscript>+</superscript> T cell expansion and severe inflammation in mice with EAM. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16616596
Volume :
22
Issue :
3
Database :
Complementary Index
Journal :
International Journal of Molecular Sciences
Publication Type :
Academic Journal
Accession number :
149925708
Full Text :
https://doi.org/10.3390/ijms22031426